第一单位：
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, United States.;Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, United States.
作者：
Laura,Cato [1]
;
Antje,Neeb [2]
;
Adam,Sharp [3]
;
Victor,Buzón [4]
;
Scott B,Ficarro [5]
;
Linxiao,Yang [6]
;
Claudia,Muhle-Goll [7]
;
Nane C,Kuznik [2]
;
Ruth,Riisnaes [3]
;
Daniel,Nava Rodrigues [3]
;
Olivier,Armant [8]
;
Victor,Gourain [2]
;
Guillaume,Adelmant [5]
;
Emmanuel A,Ntim [2]
;
Thomas,Westerling [1]
;
David,Dolling [9]
;
Pasquale,Rescigno [3]
;
Ines,Figueiredo [3]
;
Friedrich,Fauser [10]
;
Jennifer,Wu [1]
;
Jaice T,Rottenberg [1]
;
Liubov,Shatkina [2]
;
Claudia,Ester [2]
;
Burkhard,Luy [7]
;
Holger,Puchta [10]
;
Jakob,Troppmair [11]
;
Nicole,Jung [12]
;
Stefan,Bräse [13]
;
Uwe,Strähle [2]
;
Jarrod A,Marto [5]
;
Gerd Ulrich,Nienhaus [14]
;
Bissan,Al-Lazikani [15]
;
Xavier,Salvatella [16]
;
Johann S,de Bono [3]
;
Andrew Cb,Cato [2]
;
Myles,Brown [1]
作者单位：
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, United States.;Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, United States.
[1]
Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.
[2]
Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
[3]
Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, Spain.
[4]
The Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, United States.
[5]
Institute of Applied Physics, Karlsruhe Institute of Technology, Karlsruhe, Germany.
[6]
Institute for Biological Interfaces, Karlsruhe Institute of Technology, Karlsruhe, Germany.;Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany.
[7]
Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.;Institut de Radioprotection et de Sûreté Nucléaire, PRP-ENV/SERIS/LECO, Cadarache, France.
[8]
Clinical Trials and Statistics Unit, Institute of Cancer Research, London, United Kingdom.
[9]
Botanical Institute II, Karlsruhe Institute of Technology, Karlsruhe, Germany.
[10]
Daniel-Swarovski Research Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria.
[11]
Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany.
[12]
Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.;Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany.
[13]
Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.;Institute of Applied Physics, Karlsruhe Institute of Technology, Karlsruhe, Germany.;Institute of Nanotechnology, Karlsruhe Institute of Technology, Karlsruhe, Germany.;Department of Physics, University of Illinois at Urbana-Champaign, Urbana, United States.
[14]
Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom.
[15]
Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, Spain.;ICREA, Passeig Lluís Companys, Barcelona, Spain.
[16]
DOI
10.7554/eLife.27159
PMID
28826504
发布时间
2025-05-30
换一批
